FDA staff hold ‘major concerns’ with Brainstorm ALS therapy, documents show
Daiichi Sankyo reports positive results from trial of breast cancer therapy
Novo Nordisk and Valo to research cardiometabolic treatments
AbbVie ends I-Mab partnership for CD47 antibody compounds
*please scroll down for all the latest news*
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraudimage: 
Original Article
September 25 2023 – FDA staff hold ‘major concerns’ with Brainstorm ALS therapy, documents show
